Microbiota imbalance induced by dietary sugar disrupts immune-mediated protection from metabolic syndrome

Cell. 2022 Sep 15;185(19):3501-3519.e20. doi: 10.1016/j.cell.2022.08.005. Epub 2022 Aug 29.

Abstract

How intestinal microbes regulate metabolic syndrome is incompletely understood. We show that intestinal microbiota protects against development of obesity, metabolic syndrome, and pre-diabetic phenotypes by inducing commensal-specific Th17 cells. High-fat, high-sugar diet promoted metabolic disease by depleting Th17-inducing microbes, and recovery of commensal Th17 cells restored protection. Microbiota-induced Th17 cells afforded protection by regulating lipid absorption across intestinal epithelium in an IL-17-dependent manner. Diet-induced loss of protective Th17 cells was mediated by the presence of sugar. Eliminating sugar from high-fat diets protected mice from obesity and metabolic syndrome in a manner dependent on commensal-specific Th17 cells. Sugar and ILC3 promoted outgrowth of Faecalibaculum rodentium that displaced Th17-inducing microbiota. These results define dietary and microbiota factors posing risk for metabolic syndrome. They also define a microbiota-dependent mechanism for immuno-pathogenicity of dietary sugar and highlight an elaborate interaction between diet, microbiota, and intestinal immunity in regulation of metabolic disorders.

Keywords: CD36; IL-17; Th17 cells; lipid absoprtion; metabolic syndrome; micobiota; mucosal immunity; obesity; segmented filamentous bacteria; sugar.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Diet, High-Fat
  • Dietary Sugars
  • Interleukin-17
  • Intestinal Mucosa
  • Lipids
  • Metabolic Syndrome*
  • Mice
  • Mice, Inbred C57BL
  • Microbiota*
  • Obesity
  • Th17 Cells

Substances

  • Dietary Sugars
  • Interleukin-17
  • Lipids